Cargando…
Corrigendum: First‐in‐human study of milvexian, an oral, direct, small molecule factor XIa inhibitor
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010251/ https://www.ncbi.nlm.nih.gov/pubmed/35239991 http://dx.doi.org/10.1111/cts.13258 |
| _version_ | 1784687444793229312 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9010251 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90102512022-04-18 Corrigendum: First‐in‐human study of milvexian, an oral, direct, small molecule factor XIa inhibitor Clin Transl Sci Corrigenda John Wiley and Sons Inc. 2022-03-03 2022-04 /pmc/articles/PMC9010251/ /pubmed/35239991 http://dx.doi.org/10.1111/cts.13258 Text en © 2022 The Authors. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of the American Society for Clinical Pharmacology and Therapeutics. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Corrigenda Corrigendum: First‐in‐human study of milvexian, an oral, direct, small molecule factor XIa inhibitor |
| title | Corrigendum: First‐in‐human study of milvexian, an oral, direct, small molecule factor XIa inhibitor |
| title_full | Corrigendum: First‐in‐human study of milvexian, an oral, direct, small molecule factor XIa inhibitor |
| title_fullStr | Corrigendum: First‐in‐human study of milvexian, an oral, direct, small molecule factor XIa inhibitor |
| title_full_unstemmed | Corrigendum: First‐in‐human study of milvexian, an oral, direct, small molecule factor XIa inhibitor |
| title_short | Corrigendum: First‐in‐human study of milvexian, an oral, direct, small molecule factor XIa inhibitor |
| title_sort | corrigendum: first‐in‐human study of milvexian, an oral, direct, small molecule factor xia inhibitor |
| topic | Corrigenda |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010251/ https://www.ncbi.nlm.nih.gov/pubmed/35239991 http://dx.doi.org/10.1111/cts.13258 |